OSL:NAVA - Euronext Oslo - NO0010205966 - Common Stock - Currency: NOK
OSL:NAVA (5/5/2025, 7:00:00 PM)
23.2
+1.3 (+5.94%)
The current stock price of NAVA.OL is 23.2 NOK. In the past month the price increased by 9.81%. In the past year, price decreased by -27.91%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY.DE | ELI LILLY & CO | 59.72 | 686.72B | ||
1LLY.MI | ELI LILLY & CO | 59.7 | 686.53B | ||
ZEG.DE | ASTRAZENECA PLC | 19.54 | 394.99B | ||
JNJ.DE | JOHNSON & JOHNSON | 15.43 | 328.91B | ||
NOV.DE | NOVO NORDISK A/S-B | 19.96 | 268.50B | ||
1SAN.MI | SANOFI | 14.56 | 239.91B | ||
SAN.PA | SANOFI | 14.36 | 236.61B | ||
SNW.DE | SANOFI | 14.33 | 236.04B | ||
1MRKX.MI | MERCK & CO. INC. | 10.82 | 186.97B | ||
6MK.DE | MERCK & CO. INC. | 10.63 | 183.70B | ||
1PFE.MI | PFIZER INC | 7.48 | 120.06B | ||
PFE.DE | PFIZER INC | 7.46 | 119.72B |
Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo and currently employs 45 full-time employees. The company went IPO on 2006-03-31. The company is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The firm has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The firm has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
NAVAMEDIC
Henrik Ibsens gate 100
Oslo OSLO NO
Employees: 45
Phone: 4767112540
The current stock price of NAVA.OL is 23.2 NOK. The price increased by 5.94% in the last trading session.
The exchange symbol of NAVAMEDIC is NAVA and it is listed on the Euronext Oslo exchange.
NAVA.OL stock is listed on the Euronext Oslo exchange.
8 analysts have analysed NAVA.OL and the average price target is 34.68 NOK. This implies a price increase of 49.48% is expected in the next year compared to the current price of 23.2. Check the NAVAMEDIC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
NAVAMEDIC (NAVA.OL) has a market capitalization of 409.71M NOK. This makes NAVA.OL a Small Cap stock.
NAVAMEDIC (NAVA.OL) currently has 45 employees.
NAVAMEDIC (NAVA.OL) has a resistance level at 23.49. Check the full technical report for a detailed analysis of NAVA.OL support and resistance levels.
The Revenue of NAVAMEDIC (NAVA.OL) is expected to grow by 10.85% in the next year. Check the estimates tab for more information on the NAVA.OL EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NAVA.OL does not pay a dividend.
The PE ratio for NAVAMEDIC (NAVA.OL) is 331.43. This is based on the reported non-GAAP earnings per share of 0.07 and the current share price of 23.2 NOK. Check the full fundamental report for a full analysis of the valuation metrics for NAVA.OL.
ChartMill assigns a technical rating of 3 / 10 to NAVA.OL. When comparing the yearly performance of all stocks, NAVA.OL is a bad performer in the overall market: 80.35% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to NAVA.OL. Both the profitability and financial health of NAVA.OL have multiple concerns.
Over the last trailing twelve months NAVA.OL reported a non-GAAP Earnings per Share(EPS) of 0.07. The EPS decreased by -62.23% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.24% | ||
ROA | 0.26% | ||
ROE | 0.54% | ||
Debt/Equity | 0.33 |
ChartMill assigns a Buy % Consensus number of 83% to NAVA.OL. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -43.8% and a revenue growth 10.85% for NAVA.OL